JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M312402200 on December 16, 2003

J. Biol. Chem., Vol. 279, Issue 11, 9831-9839, March 12, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/11/9831    most recent
M312402200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Viegas, L. R.
Right arrow Articles by Pecci, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Viegas, L. R.
Right arrow Articles by Pecci, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Steroid Hormones Induce bcl-X Gene Expression through Direct Activation of Distal Promoter P4*

Luciana Rocha Viegas{ddagger}§, Guillermo P. Vicent§, José L. Barañao{ddagger}, Miguel Beato§, and Adalí Pecci{ddagger}

From the {ddagger}Departamento de Química Biológica de la Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires and CONICET, 1428 Buenos Aires, Argentina and §Centre de Regulació Genòmica, Barcelona, Spain

Bcl-X exists in at least five different isoforms with complex effects on programmed cell death. Glucocorticoids and progestins control bcl-X expression and influence the ratio between bcl-XL (antiapoptotic isoform) and bcl-XS (proapoptotic isoform) in different tissues. The 5'-UTR region of the mouse bcl-X gene contains at least five different promoters, which exhibit a tissue-specific pattern of promoter usage. Several mRNAs with different 5'-leading exons can be generated upon promoter activation. Here we explore the potential of the various bcl-X gene promoters to be regulated by glucocorticoids or progestins. We found that the region located immediately upstream of promoter 4 (P4) contains two hormone response element (HRE)-like sequences at positions –3040 (HRE I) and –3001 (HRE II) relative to the translation initiation codon. These HRE-like sequences confer hormone responsiveness to a core promoter and bind glucocorticoid or progesterone receptors in vitro. Point mutations of both HREs that prevent steroid receptor binding also eliminate hormonal inducibility. In cells treated with glucocorticoids, the hormone receptor is recruited to the P4 region containing the HREs. Analysis of the products of the endogenous bcl-X in epithelial mammary cells showed that only transcripts originating from P4 increased upon hormone treatment. This observation correlates with the induction of the bcl-XL mRNA, suggesting that P4 is one of the bcl-X promoters responsible for the generation of this antiapoptotic isoform.


Received for publication, November 12, 2003

* This research was supported by the University of Buenos Aires (X218), the fellowship "Arturo Oñativia-Ramón Carrillo" from Ministerio de Salud, Fundación Antorchas, and the Agencia Nacional de Promoción Científica y Tecnológica (PICT 0005-09044). Work at the Centre de Regulació Genòmica was supported by grants from the Ministerio de Ciencia y Tecnologia (PM 1999-0030) and from the Ministerio de Sanidad (SAF2001-0463). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Centre de Regulació Genòmica, Passeig Maritim 37-49, E-08003 Barcelona, Spain. Tel.: 34-93-224-09-01; Fax: 34-93-224-08-99; E-mail: miguel.beato{at}crg.es.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
A. Subtil-Rodriguez, L. Millan-Arino, I. Quiles, C. Ballare, M. Beato, and A. Jordan
Progesterone Induction of the 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Promoter in Breast Cancer Cells Involves Coordinated Recruitment of STAT5A and Progesterone Receptor to a Distal Enhancer and Polymerase Tracking
Mol. Cell. Biol., June 1, 2008; 28(11): 3830 - 3849.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Zhang, G. Tsaprailis, and G. T. Bowden
Nucleolin Stabilizes Bcl-XL Messenger RNA in Response to UVA Irradiation
Cancer Res., February 15, 2008; 68(4): 1046 - 1054.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Revil, J. Toutant, L. Shkreta, D. Garneau, P. Cloutier, and B. Chabot
Protein Kinase C-Dependent Control of Bcl-x Alternative Splicing
Mol. Cell. Biol., December 15, 2007; 27(24): 8431 - 8441.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. P. Carnevale, C. J. Proietti, M. Salatino, A. Urtreger, G. Peluffo, D. P. Edwards, V. Boonyaratanakornkit, E. H. Charreau, E. B. de Kier Joffe, R. Schillaci, et al.
Progestin Effects on Breast Cancer Cell Proliferation, Proteases Activation, and in Vivo Development of Metastatic Phenotype All Depend on Progesterone Receptor Capacity to Activate Cytoplasmic Signaling Pathways
Mol. Endocrinol., June 1, 2007; 21(6): 1335 - 1358.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Rocha-Viegas, G. P. Vicent, J. L. Baranao, M. Beato, and A. Pecci
Glucocorticoids Repress bcl-X Expression in Lymphoid Cells by Recruiting STAT5B to the P4 Promoter
J. Biol. Chem., November 10, 2006; 281(45): 33959 - 33970.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. M. Presman, E. Hoijman, N. R. Ceballos, M. D. Galigniana, and A. Pecci
Melatonin Inhibits Glucocorticoid Receptor Nuclear Translocation in Mouse Thymocytes
Endocrinology, November 1, 2006; 147(11): 5452 - 5459.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. F. Vitiello, R. J. Staversky, S. C. Gehen, C. J. Johnston, J. N. Finkelstein, T. W. Wright, and M. A. O'Reilly
p21Cip1 Protection against Hyperoxia Requires Bcl-XL and Is Uncoupled from Its Ability to Suppress Growth
Am. J. Pathol., June 1, 2006; 168(6): 1838 - 1847.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
X. Liao, S. Tang, J. B. Thrasher, T. L. Griebling, and B. Li
Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer
Mol. Cancer Ther., April 1, 2005; 4(4): 505 - 515.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. V. Delfino, M. Agostini, S. Spinicelli, P. Vito, and C. Riccardi
Decrease of Bcl-xL and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice
Blood, December 15, 2004; 104(13): 4134 - 4141.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.